Armillaria mellea

Armillaria mellea (Honey Fungus / Honey Mushroom)

1. Identity, Nomenclature, and Natural Source

Scientific name: Armillaria mellea (Vahl) P. Kumm. The species epithet mellea is Latin for "honey-colored," referring to the characteristic golden-yellow to honey-brown coloration of the fruiting bodies. Armillaria mellea, commonly known as honey fungus, is an edible basidiomycete fungus in the genus Armillaria. It is a plant pathogen and part of a cryptic species complex of closely related and morphologically similar species. Its Chinese names include míhuānjuǎn (蜜環菌) and zhènmó (榛磨); in TCM literature it is frequently encountered under the alternate romanization Mi-Huan-Ku. Armillaria mellea (Tricholomataceae) grows in symbiosis with the orchid Gastrodia elata Blume, serving as its nutrition and energy provider.

The mushroom is widely distributed in temperate regions of the Northern Hemisphere, usually in heavy soils with temperatures under 79°F (26°C). In China, A. mellea is mainly found in Hebei, Shanxi, Heilongjiang, Jilin, Zhejiang, Fujian, Guangxi, Shaanxi, Gansu, Henan, Qinghai, Yunnan, Inner Mongolia, Tibet, and Taiwan. It is very common in Heilongjiang, Liaoning, and Jilin.

The mycelium is capable of producing light via bioluminescence. The organism grows on both living and dead wood, with the honey mushrooms (fruiting bodies of A. mellea) being soft, tender, refreshing, delicious, and nutritious. Many countries have classified them as food. Honey mushrooms are umbrella-shaped, light earthy yellow, and brown when aged.

Common Forms and Preparations

• Whole dried fruiting bodies: Fresh fruiting bodies are collected from July to August, cleaned with water, and dried in the sun.
• Aqueous and ethanolic extracts: AM ethanol extract (AM-EtOH) shows stronger DPPH radical scavenging activity than AM aqueous extract (AM-H₂O).
• Fermented mycelium / fermentation liquor: The fungus is commonly used in folk medicine as a health-promoting food in various forms, such as fermented culture of mycelium for dietary supplement.
• Polysaccharide isolates: Water-soluble polysaccharides are extracted from both fruiting bodies and mycelium for use in research and functional food applications.
• Culinary uses: Armillaria mellea is considered a good edible mushroom, although the tough stalks are usually excluded. They are best collected when young and thoroughly cooked. Drying the mushrooms preserves and intensifies their flavor, although reconstituted mushrooms tend to be tough to eat. The mushrooms can also be pickled and roasted.
• Cultivation of mycelium: Cultivation of A. mellea has been present since 1994 and uses pieces of wood inoculated with the fungus. Submerged liquid fermentation is also used industrially to obtain mycelial biomass and bioactive compounds.

2. Traditional and Historical Use

The medical effect of Armillaria mellea was originally included in the ancient Chinese medicine classics "Shennong's Herbal Classic" (Shennong Bencao Jing) and "Compendium of Materia Medica" (Bencao Gangmu), and it is recorded that Armillaria mellea could be used in epilepsy, limb numbness, and headache in traditional Chinese medicine. It has been widely used in the treatment of neurological diseases, such as migraines, headaches, neurasthenia, insomnia, and epilepsy.

A. mellea can be traced back to the ancient Chinese medical masterpiece "Shen Nong Ben Cao Jing" and is widely used in dietary therapies. It was also applied to alleviate mood disorders, such as anxiety and depression, according to the "Ben Cao Gang Mu."

In traditional Chinese medicine, A. mellea is used for treatment of a variety of complaints including palsy, headache, hypertension, insomnia, dizziness, vertigo, and neurasthenia.

In China, Armillaria mellea (Vahl) P. Kumm. has been used as a folk medicine to treat insomnia for several hundred years.

Culinary-medicinal honey mushroom, or Mi-Huan-Ku, Armillaria mellea (AM), is a popular ingredient in traditional Chinese medicine for treating diseases of geriatric patients.

Relationship with Gastrodia elata and TCM Formula "Tianma"

Both A. mellea and G. elata are important components of the traditional Chinese medicine "Tianma" or "Tian-ma" (literally translated "heavenly hemp"). Because of dwindling supplies of gastrodia, its cost increased dramatically and a solution was sought in cultivating the herb. It was quite difficult to cultivate, a problem that was soon solved by finding the close relationship between gastrodia and the mycelium of Armillaria mellea. Gastrodia has an unusual requirement for growth and survival: it requires a fungus, Mycena osmundicola, to sprout its seeds, and it must have Armillaria mellea mushroom mycelia incorporated into the tuber in order to maintain its maturation and growth.

In Europe and Asia, A. mellea is considered edible and medicinal, when appropriately prepared. It has demonstrated the presence of different groups of organic compounds, including carbohydrates, sterols, sphingolipids, fatty acids, sesquiterpenes, non-hallucinogenic indole compounds, peptides, enzymes, adenosine derivatives, and many other components.

3. Key Constituents and Active Compounds

3.1 Sesquiterpene Aryl Esters (Melleolides)

Species of the basidiomycete genus Armillaria produce bioactive small molecule natural products referred to as melleolides. Chemically, they represent hybrid molecules, composed of a tricyclic, chiral sesquiterpene protoilludene alcohol, esterified with the tetraketide orsellinic acid or its derivatives. With more than 70 described members, this class constitutes a defining chemical feature of the genus.

The primary sesquiterpene aryl esters characterized from A. mellea include:

• Armillarin and armillaridin: Two new sesquiterpenoid aromatic esters, armillarin and armillaridin, were isolated from the artificially cultured mycelium of Armillaria mellea.
• Armillarikin and armillarigin: Isolation and structural elucidation of two new sesquiterpenoid aromatic esters, armillarigin and armillarikin, was reported in 1989 in Planta Medica.
• Armillaricin: Isolation and structure elucidation of armillaricin was published in Planta Medica in 1989.
• Melleolides B–D, melledonals, and armellides: Melleolides B–D are three antibacterial sesquiterpenoids from Armillaria mellea. Melleolides I and J and armellides A and B are novel sesquiterpenoid aryl esters, as are melledonals B and C, novel antibacterial sesquiterpenoids.

3.2 Polysaccharides

A water-soluble polysaccharide (AMP) was purified from the fruiting bodies. AMP contained 94.8% carbohydrate, 2.3% uronic acid, and 0.5% protein. Its molecular weight was determined as 4.6 × 10⁵ Da by high-performance gel-permeation chromatography. Gas chromatography analysis indicated that AMP was mainly composed of D-glucose.

A water-soluble polysaccharide (AMP-N-a-1), with an average molecular weight of 17 kD, was isolated and purified from the water extract of A. mellea. AMP-N-a-1 was mainly composed of Man (1.65%), Glca (1.64%), Rha (1.82%), Gala (2.49%), Glc (90.48%), Gal (0.89%), Xyl (0.42%), and Ara (0.61%).

The total β-glucan content of AM-H₂O and AM-EtOH was 21.95% and 3.50%, respectively.

3.3 Indole Compounds

Indole compounds from A. mellea include tryptamine, L-tryptophan, and serotonin. Three physiologically active indole compounds were identified: tryptamine, L-tryptophan, and serotonin. This analysis demonstrated the highest contents of L-tryptophan (4.467 mg/100 g dry weight). The contents of tryptamine were comparable with the contents of serotonin, amounting to 2.740 and 2.207 mg/100 g dry weight, respectively.

3.4 Sterols and Triterpenes

Several bioactive compounds have been isolated and identified from the fruit bodies. The triterpenes 3β-hydroxyglutin-5-ene, friedelane-2α,3β-diol, and friedelin were reported in 2011. Sphingolipids and sterols have also been described as part of the broader chemical profile.

3.5 Phenolic Compounds and Other Constituents

HPLC-DAD-MS/MS analysis showed that potassium was the most abundant mineral; chlorogenic acid was the most abundant polyphenol; malic acid was the most abundant organic acid; and among carbohydrates, the most abundant were sorbitol, glucose, fructose, and saccharose.

Bioactive compounds identified by spectrophotometric methods include ascorbic acid, tannins, total phenolics, total flavonoids, β-carotene, and lycopene.

3.6 Fibrinolytic Enzyme

The fruiting body of A. mellea produces a lysine-specific proteinase which exhibits both potent fibrinolytic activity and a remarkable resistance to denaturing agents. An improved purification protocol was developed, and the sequence of the 26 N-terminal amino acid residues of the pure protein was determined. Searches of the SwissProt database showed that the N-terminal sequence of the A. mellea proteinase is highly similar to those of lysine-specific metalloendopeptidases from the basidiomycetes Grifola frondosa and Pleurotus ostreatus.

3.7 Adenosine Derivatives

Armillaria mellea (AM) is an adenosine A1 agonist, which theoretically protects against ischemia. Adenosine and its derivatives have been listed among the characterized constituents of the fruiting bodies.

4. Established Mechanisms of Action

4.1 Pro-Apoptotic / Anticancer Mechanisms

Armillarikin inhibited the viability of human leukemia K562, U937, and HL-60 cells in a concentration-dependent manner, causing cell death mainly attributable to apoptosis accompanied by reduction of mitochondrial transmembrane potential. Armillarikin induced cleavage of caspase-8, caspase-9, caspase-3, and the caspase-3 substrate PARP. Armillarikin-induced growth inhibition and apoptosis were reversed by pan-caspase inhibitor Z-VAD-fmk, indicating a caspase-dependent effect.

Moreover, armillarikin increased production of intracellular reactive oxygen species (ROS). Prevention of ROS production attenuated armillarikin-induced apoptosis, suggesting mediation by ROS.

AMP (polysaccharide) exhibited a potent tumor growth inhibitory effect on A549 (lung cancer) cells, and induced cell cycle disruption in the G0/G1 phase, accompanied by an increment of apoptotic cells. Furthermore, AMP induced the disruption of mitochondrial membrane potential, thus leading to cytochrome c release from mitochondria and activation of caspase-3 and -9. Results demonstrate that AMP possesses strong antitumor activities through the mitochondria-dependent pathway and activation of the caspase cascade.

4.2 Neuroprotective / Antioxidant Mechanisms

AMPSc (mycelium polysaccharides) significantly enhanced cell viability, suppressed nuclear apoptosis, inhibited intracellular reactive oxygen species accumulation, prevented caspase-3 activation, and restored mitochondrial membrane potential (MMP). In AD mice, AMPSc enhanced horizontal movements in an autonomic activity test, improved endurance times in a rotarod test, and decreased escape latency time in a water maze test.

4.3 Serotonergic and Sleep Modulation

Armillaria mellea fermentation liquor (AFL) alleviated insomnia by enhancing 5-hydroxytryptamine content and the expression of 5-HT1A and 5-HT2A receptors in the hippocampus. AFL treatment also normalized the composition of gut microbiota in insomnia-model rats, increasing relative abundance of Lachnospiraceae, Ruminococcaceae, and Saccharimonadaceae.

4.4 Immunomodulatory Mechanisms

Armillaridin (AM) is an aromatic ester compound isolated from honey medicinal mushroom, Armillaria mellea, which has anti-cancer potential. This study examined the effects of AM on differentiation and activation of macrophages, the major ontogeny of innate immunity.

A. mellea contains various known and untapped bioactive metabolites such as polysaccharides, sesquiterpene aryl esters, steroids, and fibrinolytic enzymes. It could be exploited as an important source of new biological natural products with anticonvulsant, immunomodulatory, and antimicrobial functions.

4.5 Fibrinolytic Mechanism

These data suggest that the fibrinolytic enzyme AMMP, obtained from A. mellea, exhibits a profound fibrinolytic activity. The mycelia of A. mellea may thus represent a potential source of new therapeutic agents to treat thrombosis.

4.6 Adenosine A1 Receptor Agonism

Kidney, heart (arrhythmia or angina pectoris), peripheral nociceptive nerves belong to the theoretical range of action of adenosine A1 agonists, as well as epilepsy control. As a putative adenosine A1 agonist, A. mellea extracts have attracted interest for their potential cardioprotective and anticonvulsant roles, though clinical confirmation is lacking.

5. Scientific Evidence by Area of Use

5.1 Neurological Conditions (Dizziness, Vertigo, Neurasthenia)

Armillaria mellea (AM) is an adenosine A1 agonist which theoretically protects against ischemia. Its effects against dizziness are supported by a randomized double-blind study. This represents one of the relatively few controlled clinical trial references for A. mellea in humans. However, the full details and population size of this trial are not widely available in primary English-language literature. Extracts from Armillaria mellea have been reported to show various pharmacological effects, including retarding aging, hypnosis, calmness, improving immunity, and neuron protection.

Evidence strength: There is limited human clinical evidence specific to A. mellea for neurological conditions. The bulk of evidence for neuroprotective effects is preclinical (animal and cell-based studies).

5.2 Alzheimer's Disease and Cognitive Function

Armillaria mellea has been used for hundreds of years in East Asia as an edible and medicinal fungus. L-Glu-induced HT22 apoptotic cells and D-gal plus AlCl₃-induced AD mice were used to investigate the neuroprotective effects of A. mellea mycelium polysaccharides (AMPS). In HT22 cells, AMPS improved cell viability, restored mitochondrial membrane potential (MMP), and reduced cell apoptosis and excess caspase-3 activity. Moreover, AMPS treatment regulated the behavior and physiological and biochemical indexes of AD mice. Taken together, the data suggest the usefulness of A. mellea as a therapeutic agent or functional food for the treatment of AD.

Studies have shown that Armillaria mellea polysaccharide (AMP) can treat Alzheimer's disease (AD) through anti-apoptosis and anti-oxidation. However, systematic studies on the relationship between the effect of AMP on the neurogenesis of the hippocampus and the improvement of learning and memory are still insufficient.

Evidence strength: Currently confined to in vitro cell studies and animal models. No human clinical trials on Alzheimer's disease have been published using A. mellea as the primary intervention.

5.3 Insomnia and Sleep

As a well-known traditional Chinese medicine, Armillaria mellea has been clinically employed in the treatment of insomnia for centuries in Asia with significant efficacy. However, modern controlled clinical trial data are sparse. A 2022 rodent study (n=6 per group) demonstrated that AFL alleviated insomnia by enhancing 5-hydroxytryptamine content and the expression of 5-HT1A and 5-HT2A receptors in the hippocampus. AFL treatment also normalized the composition of gut microbiota in insomnia-model rats. The experiments show that A. mellea alleviated insomnia by modulating the serotonergic system and gut microbiota.

Evidence strength: Preclinical (animal pharmacology). No randomized controlled human trials have been identified specifically for insomnia endpoints with A. mellea alone.

5.4 Anticancer Activity

Several compounds found in A. mellea have potential antitumor or cytotoxicity effects, including armillarikin, armillaridin, other melleolides, and arnamial. This medicinal mushroom is also used as a dietary supplement in numerous Western and Eastern countries. Armillarikin was isolated from A. mellea, and was previously discovered to induce cytotoxicity in human leukemia cells. Cytotoxicity of armillarikin was further investigated against liver and intrahepatic bile duct cancer cells. Armillarikin was cytotoxic against human hepatocellular carcinoma Huh7, HA22T, and HepG2 cells.

Armillarikin is known to have cytotoxic effects against HCC, leukemia, lung, and colon cancers.

Armillaridin can hinder the proliferation of Huh7, HepG2, and HA22T hepatocellular carcinoma cells through the disruption of the mitochondrial transmembrane potential. Additionally, armillaridin can promote the death of HCC cells through autophagy. Armillaridin has also been found to inhibit the growth of human chronic granulocytic leukemia K562 cells and induce autophagy-associated cell death.

The polysaccharide structure of A. mellea is primarily composed of D-glucose. Previous studies suggest that Armillaria mellea polysaccharides may have antitumor activity by inducing apoptosis and cell blockade in A549 cells.

Evidence strength: All anticancer studies to date are in vitro (cell culture) studies. No human or animal tumor model clinical trials have been published demonstrating therapeutic benefit in oncology patients.

5.5 Antioxidant Activity

Antioxidative activity was assessed by DPPH (IC50 of the methanolic extract was 608.32 μg/mL and of the acetonic extract 595.71 μg/mL) and reducing power assays (results ranged between 0.034 and 0.102 μg/mL). Total phenolic content was determined as 4.74 mg GAE/g (methanolic extract) and 5.68 mg GAE/g (acetonic extract).

AM ethanol extract (AM-EtOH) showed stronger DPPH radical scavenging activity than AM aqueous extract (AM-H₂O). However, they were weak in metal chelation and reducing power.

Total phenolic contents of 21.68 ± 0.06 and 5.70 ± 0.28 mg/g were determined in the hydromethanolic and ethanolic extracts, respectively.

Evidence strength: Moderate in vitro evidence for antioxidant activity; results vary by extraction method and solvent. No human intervention trials have measured antioxidant outcomes.

5.6 Antidiabetic / Antihyperglycemic Activity

The antidiabetic effect of the extracts was tested by the α-amylase (results ranged from 34.90% to 41.98%) and α-glucosidase assays (results were in the range of 0.55–2.79%).

The antidiabetic activity of UE-AMPs was investigated in streptozotocin (STZ)-induced diabetic mice. UE-AMPs, when given by gavage, greatly prevented weight loss, increased water intake, and considerably decreased blood glucose levels in diabetic mice, which were dose-dependent (P < 0.05).

Armillaria mellea extracts showed antioxidant and antihyperglycemic potential in in vitro models and therefore they are promising candidates for the development of dietary supplements and pharmaceutical products.

Evidence strength: Preliminary in vitro enzyme inhibition assays and one animal (rodent) model. No human clinical trials have evaluated glycemic outcomes.

5.7 Antimicrobial Activity

The microdilution assay was used to evaluate the antimicrobial activity of the extracts, and the results ranged from 1.25 to 20 mg/mL. Although some results suggest that some activities of the extracts are relatively moderate, the honey mushroom can still be considered an excellent source of food and bioactive compounds with medicinal value.

Melleolides B–D are three antibacterial sesquiterpenoids from Armillaria mellea.

Evidence strength: In vitro only. The minimum inhibitory concentrations (1.25–20 mg/mL) observed in these assays are relatively moderate and far from concentrations achievable through dietary supplementation.

5.8 Anti-inflammatory and Antiedema Activity

AM-EtOH but not AM-H₂O at 200 mg/kg showed antiedema activity in rats.

Compared with the model group, AMP-treated mice presented significantly lower interleukin-6 (IL-6) levels (p < 0.05) and significantly greater superoxide dismutase (SOD) activity, indicating improved antioxidant capacity.

Evidence strength: Animal models and in vitro data only. No human anti-inflammatory trials have been conducted.

5.9 Chronic Fatigue

A 2026 study aimed to investigate the effects of Armillaria mellea polysaccharide (AMP) on oxidative stress and the gut microbiota in chronic fatigue (CF) model mice. The CF model was established via daily restrained running wheel tests combined with nocturnal noise exposure, and the mice were orally administered AMP at graded doses (100–400 mg/kg). The AMP intervention significantly increased the abundance of lactic acid bacteria in the intestinal tract of the mice. These findings demonstrate that AMP can serve as a natural dietary supplement with potential therapeutic value for CF intervention.

Evidence strength: Animal model only; no human trials.

5.10 Neuroprotection: Depression and Mood

Researchers believe that AM may possess pharmacological properties similar to Gastrodia elata due to their symbiosis; however, few studies have investigated the pharmacological effect of AM specifically. A rodent study tested water extract of A. mellea in acute- and chronic mild stress-induced rodent models of depression and demonstrated anti-inflammatory action in those models.

Evidence strength: Animal models only. No human data are available for mood or depression outcomes.

6. Body Systems and Health Areas Associated with Armillaria mellea

• Central Nervous System: Extracts from Armillaria mellea have been reported to show various pharmacological effects, including retarding aging, hypnosis, calmness, improving immunity, and neuron protection.
• Immune System: Multiple in vitro and in vivo experiments have confirmed that AMPs have various pharmacological effects including immunomodulatory, anti-tumor, antidiabetic, anti-dementia, antioxidant, anti-inflammatory, and hypolipidaemic activities.
• Cardiovascular / Hemostatic System: One must consider its fibrinolytic action whilst recommending AM to patients presenting with ischemia, especially those already receiving anti-aggregant medications or anticoagulation agents.
• Metabolic / Endocrine System: Antidiabetic and antihyperglycemic effects have been observed in vitro and in rodent models, mediated through α-glucosidase inhibition and insulin-sensitizing mechanisms in animal studies.
• Gastrointestinal System: AFL treatment normalized the composition of gut microbiota in insomnia-model rats, restoring the gut microbial ecosystem altered in insomnia rats.
• Oncology (preclinical): A. mellea stands out due to its abundant biologically active components. The presence of biological compounds in AM, including carbohydrates, sterols, fatty acids, sesquiterpenes, non-hallucinogenic indole compounds, and adenosine derivatives, has been demonstrated in previous studies. Specific bioactive substances isolated from AM, such as armillarikin, have exhibited promising anticancer effects. In vitro studies have elucidated the mechanisms behind these effects.

7. Dosage Forms and Dosages Reported in Studies

No established human clinical dose has been formally defined for Armillaria mellea as a dietary supplement in Western regulatory frameworks. The following dosages are drawn directly from the experimental literature:

• Antiedema study (rats): AM-EtOH at 200 mg/kg showed antiedema activity in rats.
• Alzheimer's disease model (mice): L-Glu-induced HT22 apoptotic cells and D-gal plus AlCl₃-induced AD mice were used to investigate the neuroprotective effects of A. mellea mycelium polysaccharides (AMPS). Specific oral doses in the murine model are reported in the primary paper.
• Chronic fatigue model (mice): Mice were orally administered AMP at graded doses (100–400 mg/kg).
• Antidiabetic model (mice, gavage): The antidiabetic activity of UE-AMPs was investigated in STZ-induced diabetic mice. UE-AMPs, when given by gavage, considerably decreased blood glucose levels in a dose-dependent manner (P < 0.05).
• Insomnia model (rats): Effects of A. mellea fermentation liquor on the sedative and hypnotic mechanisms were assessed in insomnia rats (n = 6 per group), with several physiological metrics including weight gain, locomotor activity, sleep latency, and sleep duration monitored.
• Dietary supplement forms: A. mellea is currently used as a dietary supplement in numerous Western and Eastern countries. Commercially available preparations include dried powdered fruiting body capsules, mycelium fermentation products, and standardized extracts; however, no standardized dose for any supplement form has been validated in controlled human trials.

8. Safety Considerations and Interactions

8.1 General Safety and Cooking Requirement

Armillaria mellea is considered a good edible mushroom, best collected when young and thoroughly cooked. Parboiling mushrooms before consuming removes the bitter taste present in some specimens and may reduce the amount of gastrointestinal irritants. According to one guide, they must be cooked before eating. Specimens such as those growing on buckeye or hemlock can cause gastrointestinal upset.

8.2 Gastrointestinal Irritation (Raw Consumption)

The honey mushroom is generally not considered toxic, but there are reports of people having stomach upsets the first time it is eaten. It is advisable to try the honey mushroom in small quantities, and it should always be fully cooked before consumption.

8.3 Heavy Metal Accumulation

The results of quantitative analyses of indole compounds and heavy metals signal potential health hazards for humans. Research has investigated heavy metals (Cd, Cr, Cu, Ni, and Pb) in the fruiting bodies of wild edible mushrooms, including Armillaria mellea, correlated with various factors such as the growth substrate and the sampling site. Wild-collected specimens from industrially contaminated areas may carry elevated heavy metal loads; this risk is reduced in commercially cultivated products from controlled growing environments.

8.4 Indole Compound Content

Three physiologically active indole compounds were identified in fruiting bodies: tryptamine, L-tryptophan, and serotonin. The highest contents of L-tryptophan were 4.467 mg/100 g dry weight. The contents of tryptamine were comparable with the contents of serotonin, amounting to 2.740 and 2.207 mg/100 g dry weight, respectively. Although these are described as non-hallucinogenic indole compounds, their presence at quantifiable levels warrants consideration in individuals receiving serotonergic medications.

8.5 Fibrinolytic Activity and Drug Interactions

AM stimulates immunity and possesses antioxidative and antibiotic properties. One must consider its fibrinolytic action whilst recommending AM to patients presenting with ischemia, especially those already receiving anti-aggregant medications or anticoagulation agents. The lysine-specific fibrinolytic proteinase isolated from A. mellea mycelia could theoretically potentiate the effects of anticoagulant and antiplatelet drugs.

8.6 Acute Toxicity of Polysaccharides

Although most polysaccharides have low toxicity and no significant side effects, it is still necessary to evaluate the potential risks and toxicity of polysaccharides in detail before clinical research. Among the more than hundreds of publications on AMPs, only one research has studied the acute toxicity of A. mellea polysaccharides (AMPs). The limited safety data specifically for A. mellea polysaccharide extracts highlights a significant gap in the pre-clinical toxicology literature.

8.7 Immunomodulatory Caution

Armillaridin, an aromatic ester compound isolated from honey medicinal mushroom Armillaria mellea, has demonstrated anti-cancer potential and effects on macrophage differentiation and activation. Immunomodulatory compounds may theoretically interact with immunosuppressive therapies (e.g., in transplant patients), though no interaction studies in humans have been published.

8.8 Evidence Gaps and Overall Safety Characterization

The totality of safety data for Armillaria mellea as a dietary supplement remains limited. It is considered in Europe and Asia as edible and medicinal, when appropriately prepared, and has demonstrated the presence of different groups of organic compounds. Most of these metabolite groups possess potential therapeutic and dietary values. The results of quantitative analyses of indole compounds and heavy metals signal potential health hazards for humans. Systematic clinical pharmacovigilance or formal adverse event reporting for A. mellea supplement products has not been identified in the peer-reviewed literature.

References

• Huang K, Xu B. Critical review of the phytochemical profiles and health-promoting effects of the edible mushroom Armillaria mellea. Food Funct. 2023;14:9518–9533. PubMed.
• Kostić M et al. Chemical Characterization and Bioactive Properties of the Edible and Medicinal Honey Mushroom Armillaria mellea (Agaricomycetes) from Serbia. Int J Med Mushrooms. 2023. PubMed.
• Lung MY, Chang YC. Antioxidant and antiedema properties of solid-state cultured honey mushroom, Armillaria mellea, extracts. Int J Med Mushrooms. 2013;15(2). PubMed.
• Armillaria mellea: phenolic content, in vitro antioxidant and antihyperglycemic effects. PubMed.
• Liu TP et al. Armillaridin, a Honey Medicinal Mushroom, Armillaria mellea (Higher Basidiomycetes) Component, Inhibits Differentiation and Activation of Human Macrophages. Int J Med Mushrooms. 2015;17(2). PubMed.
• Effects of an Armillaria mellea Polysaccharide on Learning and Memory of D-Galactose-Induced Aging Mice. Front Pharmacol. 2022;13:919920. PMC.
• Chemical, pharmacological, and biological characterization of the culinary-medicinal honey mushroom, Armillaria mellea (Vahl) P. Kumm. (Agaricomycetideae): a review. Int J Med Mushrooms. 2011;13(2). PubMed.
• Chemical Composition, Bioactive Compounds, and Antioxidant Activity of Two Wild Edible Mushrooms Armillaria mellea and Macrolepiota procera. PubMed. 2021.
• Induction of apoptosis by Armillaria mellea constituent armillarikin in human hepatocellular carcinoma. PMC. 2016.
• A polysaccharide from Armillaria mellea exhibits strong in vitro anticancer activity via apoptosis-involved mechanisms. PubMed. 2012.
• Pharmacological Basis for Use of Armillaria mellea Polysaccharides in Alzheimer's Disease: Antiapoptosis and Antioxidation. PMC. 2017.
• Armillaria mellea component armillarikin induces apoptosis in human leukemia cells. J Funct Foods. 2014;6:196–204. ScienceDirect.
• Yao et al. Armillaria mellea fermentation liquor ameliorates p-chlorophenylalanine-induced insomnia associated with the modulation of serotonergic system and gut microbiota in rats. J Food Biochem. 2022. Wiley.
• Water extract of Armillaria mellea alleviates depression-like behaviors in acute- and chronic mild stress-induced rodent models via anti-inflammatory action. J Ethnopharmacol. 2021;265:113395. ScienceDirect.
• Extraction, purification, structural characteristics and biological properties of the polysaccharides from Armillaria mellea (Vahl) P. Kumm.: A review. ScienceDirect. 2024.
• Dörfer M, Gressler M, Hoffmeister D. Diversity and bioactivity of Armillaria sesquiterpene aryl ester natural products. Mycol Prog. 2019;18:1027–1037. Springer.
• The Lysine-Specific Proteinase from Armillaria mellea Is a Member of a Novel Class of Metalloendopeptidases Located in Basidiomycetes. Biochem Biophys Res Commun. 1999. ScienceDirect.
• Antidiabetic activity of Armillaria mellea polysaccharides: Joint ultrasonic and enzyme assisted extraction. PMC. 2023.
• Armillaria mellea Mycelium Aqueous Extract-Induced Apoptosis in A549 Cells via a Caspase-Mediated Pathway. Biol Bull. 2025. Springer.
• Armillaria mellea polysaccharide improves chronic fatigue through intestinal flora. PubMed. 2026.
• L'Armillaire miel: un agoniste adénosine A1 actif contre les vertiges et un agent potentiel contre les effets délétères de l'ischémie. Phytothérapie. 2013. Springer.
• Armillaria mellea. Wikipedia.
• Gao LW et al. The cultivation, bioactive components and pharmacological effects of Armillaria mellea. Afr J Biotechnol. African Journals Online.
• Yang JS et al. Chemical constituents of Armillaria mellea mycelium I. Isolation and characterization of armillarin and armillaridin. Planta Med. 1984;50:288–290. PubMed.
• Modernizing Chinese Medicine: The Case of Armillaria as a Gastrodia Substitute. Institute for Traditional Medicine.
• Network Pharmacology Analysis of Liquid-Cultured Armillaria ostoyae Mycelial Metabolites and Their Molecular Mechanism of Action against Gastric Cancer. PMC. 2024.